SUVENHealthcare Research, Analytics & Technology
Suven Life Sciences Ltd — Balance Sheet
₹131.70
-2.75%
Suven Life Sciences Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 21.81 Cr | 21.81 Cr | 21.81 Cr | 15.78 Cr | — |
| Share Issued | 21.81 Cr | 21.81 Cr | 21.81 Cr | 15.78 Cr | — |
| Total Debt | 0.00 | 0.71 Cr | 1.61 Cr | 3.21 Cr | — |
| Tangible Book Value | 109.81 Cr | 269.84 Cr | 375.12 Cr | 95.92 Cr | — |
| Invested Capital | 109.99 Cr | 270.04 Cr | 375.32 Cr | 96.63 Cr | — |
| Working Capital | 51.99 Cr | 243.16 Cr | 240.46 Cr | 58.28 Cr | — |
| Net Tangible Assets | 109.81 Cr | 269.84 Cr | 375.12 Cr | 95.92 Cr | — |
| Capital Lease Obligations | 0.00 | 0.71 Cr | 1.61 Cr | 2.72 Cr | — |
| Common Stock Equity | 109.99 Cr | 270.04 Cr | 375.32 Cr | 96.15 Cr | — |
| Total Capitalization | 109.99 Cr | 270.04 Cr | 375.32 Cr | 96.15 Cr | — |
| Total Equity Gross Minority Interest | 109.99 Cr | 270.04 Cr | 375.32 Cr | 96.15 Cr | — |
| Stockholders Equity | 109.99 Cr | 270.04 Cr | 375.32 Cr | 96.15 Cr | — |
| Other Equity Interest | 1.27 Cr | 248.23 Cr | 353.51 Cr | 81.61 Cr | — |
| Retained Earnings | -600.67 Cr | -439.87 Cr | -334.73 Cr | -216.65 Cr | — |
| Additional Paid In Capital | 646.78 Cr | 646.78 Cr | 646.78 Cr | 256.65 Cr | — |
| Capital Stock | 21.81 Cr | 21.81 Cr | 21.81 Cr | 14.54 Cr | — |
| Common Stock | 21.81 Cr | 21.81 Cr | 21.81 Cr | 14.54 Cr | — |
| Total Liabilities Net Minority Interest | 25.20 Cr | 14.86 Cr | 13.59 Cr | 11.89 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 1.71 Cr | 1.35 Cr | 2.46 Cr | 3.57 Cr | — |
| Non Current Pension And Other Postretirement Benefit Plans | 1.71 Cr | 1.35 Cr | 1.88 Cr | 2.00 Cr | — |
| Current Liabilities | 23.49 Cr | 13.52 Cr | 11.13 Cr | 8.31 Cr | — |
| Other Current Liabilities | 0.60 Cr | 0.51 Cr | 0.54 Cr | 0.69 Cr | — |
| Current Debt And Capital Lease Obligation | 0.00 | 0.71 Cr | 1.03 Cr | 1.64 Cr | — |
| Current Capital Lease Obligation | 0.00 | 0.71 Cr | 1.03 Cr | 1.15 Cr | — |
| Pensionand Other Post Retirement Benefit Plans Current | 1.64 Cr | 1.12 Cr | 1.03 Cr | 0.89 Cr | — |
| Payables | 5.23 Cr | 2.12 Cr | 1.86 Cr | 2.60 Cr | — |
| Dividends Payable | 0.00 | 0.05 Cr | 0.19 Cr | 0.25 Cr | — |
| Accounts Payable | 5.23 Cr | 2.07 Cr | 1.66 Cr | 1.99 Cr | — |
| Total Assets | 135.18 Cr | 284.90 Cr | 388.91 Cr | 108.03 Cr | — |
| Total Non Current Assets | 59.71 Cr | 28.23 Cr | 137.32 Cr | 41.44 Cr | — |
| Non Current Prepaid Assets | 0.05 Cr | 0.01 Cr | 0.01 Cr | 0.33 Cr | — |
| Non Current Deferred Taxes Assets | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Investmentin Financial Assets | 0.05 Cr | 0.00 | 100.00 Cr | 0.00 | — |
| Available For Sale Securities | 0.05 Cr | 0.01 Cr | 100.00 Cr | — | — |
| Goodwill And Other Intangible Assets | 0.18 Cr | 0.20 Cr | 0.20 Cr | 0.22 Cr | — |
| Other Intangible Assets | 0.18 Cr | 0.20 Cr | 0.20 Cr | 0.22 Cr | — |
| Net PPE | 59.48 Cr | 28.02 Cr | 37.11 Cr | 41.22 Cr | — |
| Accumulated Depreciation | -52.94 Cr | -49.25 Cr | -50.60 Cr | -44.97 Cr | — |
| Gross PPE | 112.42 Cr | 77.27 Cr | 87.71 Cr | 86.18 Cr | — |
| Construction In Progress | 97000.00 | 59000.00 | 0.09 Cr | 3.88 Cr | — |
| Other Properties | 75.67 Cr | 73.14 Cr | 83.50 Cr | 78.52 Cr | — |
| Machinery Furniture Equipment | 3.81 Cr | 3.80 Cr | 3.80 Cr | 3.47 Cr | — |
| Land And Improvements | 32.93 Cr | 0.32 Cr | 0.32 Cr | 0.32 Cr | — |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Assets | 75.47 Cr | 256.67 Cr | 251.59 Cr | 66.59 Cr | — |
| Other Current Assets | -2000.00 | 10.77 Cr | -1000.00 | -2000.00 | — |
| Restricted Cash | 22.70 Cr | 149.05 Cr | 147.26 Cr | 0.25 Cr | — |
| Prepaid Assets | 12.63 Cr | 10.77 Cr | 8.42 Cr | 6.32 Cr | — |
| Inventory | 0.24 Cr | 0.71 Cr | 0.00 | 0.02 Cr | — |
| Raw Materials | 0.24 Cr | 0.71 Cr | 0.00 | — | — |
| Other Receivables | 0.08 Cr | 2.20 Cr | 4.77 Cr | 0.75 Cr | — |
| Taxes Receivable | 1.19 Cr | 1.80 Cr | 6.97 Cr | 7.52 Cr | — |
| Accounts Receivable | 1.34 Cr | 1.29 Cr | 0.81 Cr | 1.30 Cr | — |
| Allowance For Doubtful Accounts Receivable | -27000.00 | -50000.00 | 0.00 | 0.00 | — |
| Gross Accounts Receivable | 1.34 Cr | 1.29 Cr | 0.81 Cr | 1.30 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 37.30 Cr | 90.87 Cr | 83.36 Cr | 50.44 Cr | — |
| Other Short Term Investments | 22.28 Cr | 75.94 Cr | 46.34 Cr | 45.16 Cr | — |
| Cash And Cash Equivalents | 15.03 Cr | 14.93 Cr | 37.02 Cr | 5.27 Cr | — |
| Cash Financial | 15.03 Cr | 14.93 Cr | 12.02 Cr | 5.27 Cr | — |
| Other Non Current Liabilities | — | -1000.00 | -1000.00 | -1000.00 | 0.06 Cr |
| Long Term Debt And Capital Lease Obligation | — | 0.00 | 0.58 Cr | 1.57 Cr | 2.72 Cr |
| Long Term Capital Lease Obligation | — | 0.00 | 0.58 Cr | 1.57 Cr | 2.33 Cr |
| Long Term Debt | — | 0.00 | 0.00 | 0.00 | 0.39 Cr |
| Long Term Provisions | — | 1.35 Cr | 1.88 Cr | 2.00 Cr | 1.73 Cr |
| Current Debt | — | 0.00 | 0.00 | 0.48 Cr | 0.94 Cr |
| Other Non Current Assets | — | 64000.00 | 2000.00 | 0.33 Cr | — |
| Cash Equivalents | — | 0.00 | 25.00 Cr | 0.00 | — |
| Non Current Deferred Taxes Liabilities | — | — | — | 0.00 | 0.00 |
| Other Payable | — | — | — | 0.37 Cr | 1.16 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Suven Life Sciences Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.